We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA批准了zuranolone，裸盖菇素通过III期临床试验，Caplyta将缓解几率翻倍。了解如何摆脱血清素理论以及新的NMDA拮抗剂在2026年改变精神病学。
